Table 2.
Participants | Age | Sex | Comorbidity | BMI (kg/m2) | Access to caregiver | Phase 1 (number of weeks) | Phase 2 (number of weeks) | Number of supervised sessions | Intensive care stay |
---|---|---|---|---|---|---|---|---|---|
1 | 49 | M | HBP, HC | 21.5 | Yes | 3 | 2 | 8 | Yes |
2 | 56 | F | Asthma, HC, HT4 | 32.4 | No | 1 | 2 | 4 | No |
3 | 80 | M | DB, Asthma | 28.6 | Yes | 1 | N/A | 2 | Yes |
4 | 59 | M | N/A | 30.9 | No | 5 | 3 | 13 | Yes |
5 | 64 | M | HBP, HC | 23.9 | No | 7 | 1 | 15 | Yes |
6 | 53 | F | HBP, KD | 39.3 | Yes | 8 | 0 | 16 | Yes |
7 | 49 | F | N/A | 27.0 | No | 1 | 4 | 6 | No |
Note. M: Male; F: Female; HBP: high blood pressure; HC: hypercholesterolemia; HT4: Hypothyroidism; DB: Diabetes; KD: Kidney disease